0 Kommentare
0 Geteilt
596 Ansichten
0 Bewertungen
Suche
Entdecken Sie neue Leute, knüpfen Sie neue Kontakte und schließen Sie neue Freundschaften
-
Bitte loggen Sie sich ein, um liken, teilen und zu kommentieren!
-
HER2 Positive Breast Cancer Market Size, Targeted Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period For structuring the finest market...0 Kommentare 0 Geteilt 242 Ansichten 0 Bewertungen
-
HER2 Positive Breast Cancer Treatment Market Size, Targeted Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period The HER2 Positive Breast Cancer...0 Kommentare 0 Geteilt 71 Ansichten 0 Bewertungen
-
Salivary Gland Cancer Treatment Market: Targeted Therapy Pipeline, Precision Oncology Strategies"Executive Summary Salivary Gland Cancer Treatment Market Size and Share Analysis Report The global salivary gland cancer treatment market size was valued at USD 1.78 billion in 2024 and is expected to reach USD 3.27 billion by 2032, at a CAGR of 7.90% during the forecast period The global Salivary Gland Cancer Treatment Market research report has...0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen
-
Burkitt Lymphoma Therapeutics Market Size, Share & Growth Analysis Report 2025–2034Get Your Sample Report Here: https://reedintelligence.com/market-analysis/burkitt-lymphoma-therapeutics-market/request-sample Buy Now: https://reedintelligence.com/market-analysis/burkitt-lymphoma-therapeutics-market Burkitt Lymphoma Therapeutics Market Overview The global Burkitt Lymphoma Therapeutics Market is experiencing significant growth due to the increasing prevalence of lymphoma...0 Kommentare 0 Geteilt 911 Ansichten 0 Bewertungen
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Kommentare 0 Geteilt 5KB Ansichten 0 Bewertungen
-
Emerging Trends Influencing the Antibody Drug Conjugates MarketAsia-Pacific is expected to witness rapid growth in the coming years due to increasing healthcare investments and expanding pharmaceutical manufacturing capabilities. Countries like China and India are emerging as important research hubs. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023,...0 Kommentare 0 Geteilt 8KB Ansichten 0 Bewertungen
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen
-
Global Cervical Cancer Therapeutics Market Future Growth ProspectsThe global cervical cancer therapeutics market size was valued at USD 6.33 billion in 2024 and is expected to grow from USD 6.61 billion in 2025 to reach USD 9.38 billion in 2033, growing at a CAGR of 4.47% during the forecast period (2025–2033). Key Highlights North America dominated the global cervical cancer therapeutics market and is expected to maintain its leading...0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen
-
Global High Potent API (HPAPI) Market — Trends and Market Leaders & Key Company ProfilesThe global high potent API (HPAPI) market is experiencing exceptional growth momentum, driven by the surging demand for targeted cancer therapies, rapid advancements in containment and manufacturing technologies, and a structural shift toward outsourced pharmaceutical production. According to The Insight Partners, the high potent API market was valued at US$ 28.82 Billion in...0 Kommentare 0 Geteilt 5KB Ansichten 0 Bewertungen
-
How Are Treatments Advancing in Metastatic Solid Tumors Market?Executive Summary Metastatic Solid Tumors Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029. The Metastatic Solid Tumors report is an ultimate solution for businesses if they want to stay ahead of the competition in today's fast-moving business...0 Kommentare 0 Geteilt 2KB Ansichten 0 Bewertungen
-
Immunotherapy Impact on the Anti-cancer Drugs MarketThe rapid growth of the biotechnology sector is supporting breakthroughs in anti-cancer drug development. Researchers are leveraging advanced technologies such as gene therapy and cell-based therapies. These innovations are opening new possibilities in cancer treatment. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and...0 Kommentare 0 Geteilt 6KB Ansichten 0 Bewertungen
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Kommentare 0 Geteilt 3KB Ansichten 0 Bewertungen
Weitere Ergebnisse
© 2026 Myliveroom — Live Events & Online Communities
Deutsch